Upstream Bio logo
Upstream Bio
UPB | NASDAQ
Chart Builder DCF Calculator
$2.15
-$0.63 (-22.66%)
At close: Nov 16, 2026, 4:00 PM ET
$2.19
+$0.04 (+1.64%)
After-hours: Nov 16, 2026, 7:36 PM ET

Upstream Bio Company Profile

Company profile explained

Company Profile

Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.

Key Executives

Name Position
E. Rand Sutherland Chief Executive Officer & Director
Michael Paul Gray Chief Financial Officer & Chief Operating Officer
Stacy Price Chief Technology Officer
Aaron Deykin Chief Medical Officer and Head of Research & Development
Adam Houghton Chief Business Officer
Allison Ambrose Senior Vice President, General Counsel & Secretary
Fang Xie Vice President & Head of Biometrics
Lisa Fiering Senior Vice President of People & Culture
Meggan Buckwell Director of Corporate Communications & Investor Relations
Mersedeh Miraliakbari Senior Vice President of Regulatory Affairs & Quality

Latest SEC Filings

Date Type Title
Oct 29, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 17, 2026 4 Filing
Sep 01, 2026 8-K Current Report
Aug 12, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 11, 2026 10-Q Quarterly Report
Aug 11, 2026 8-K Current Report
View All SEC Filings ➞
Upstream Bio
Upstream Bio logo
Country United States
IPO Date Oct 11, 2024
Industry Biotechnology
Sector Healthcare
Employees 75
CEO E. Rand Sutherland

Contact Details

890 Winter Street Waltham, Massachusetts 02451 United States

Stock Details

Ticker Symbol UPB
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002022626
CUSIP Number 91678A107
ISIN Number US91678A1079
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.